Philips to convene Extraordinary General Meeting of Shareholders
May 07 2020 - 5:00AM
Philips to convene Extraordinary General Meeting of Shareholders
May 7, 2020
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA) today announced that it will convene an
Extraordinary General Meeting of Shareholders (EGM) and publish the
agenda with explanatory note shortly. The sole purpose of the EGM
is submit to Philips’ shareholders the revised proposal, as
announced on April 20, 2020, to declare a distribution of EUR 0.85
per common share against the net income for 2019, in shares
only.
The EGM is scheduled to be held on June 26, 2020, beginning at
11:00 hours CET. To protect the health and safety of all
participants in connection with COVID-19 and considering the
temporary legislative measures from the Dutch government,
shareholders are invited to submit their voting instructions and
follow the meeting via the live webcast only, which will be
available on Philips’ website.
Upon convocation, the agenda with explanatory note and other
information relevant for the EGM will be available here.
If the above dividend proposal is adopted, the dividend
timetable will be as follows:
|
Ex-dividend date |
June 30, 2020 |
|
Dividend record date |
July 1, 2020 |
|
Announcement of ratio and number of dividend shares |
July 6, 2020 |
|
Payment date |
As from July 7, 2020 |
The number of share dividend rights entitled to one new common
share will be determined based on the volume-weighted average price
of all traded common shares of Koninklijke Philips N.V. at Euronext
Amsterdam on June 30, and July 1 and 2, 2020. The company will
calculate the number of share dividend rights entitled to one new
common share, such that the gross dividend in shares would be
approximately equal to EUR 0.85.
For further information, please contact:
Ben ZwirsPhilips Global Press OfficeTel.: +31 6 15213446E-mail:
ben.zwirs@philips.com
Derya GuzelPhilips Investor RelationsTel.: +31 20 59
77055E-mail: derya.guzel@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips' health technology portfolio generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter
Forward-looking statements This release
contains certain forward-looking statements with respect to the
financial condition, results of operations and business of Philips
and certain of the plans and objectives of Philips with respect to
these items. Examples of forward-looking statements include
statements made about the strategy, estimates of sales growth,
future EBITA, future developments in Philips’ organic business and
the completion of acquisitions and divestments. By their nature,
these statements involve risk and uncertainty because they relate
to future events and circumstances and there are many factors that
could cause actual results and developments to differ materially
from those expressed or implied by these statements.
This press release contains inside information within the
meaning of Article 7(1) of the EU Market Abuse Regulation.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024
